nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—Balsalazide—Crohn's disease	0.331	0.387	CbGbCtD
Telmisartan—PPARG—Mesalazine—Crohn's disease	0.264	0.31	CbGbCtD
Telmisartan—PPARG—Sulfasalazine—Crohn's disease	0.148	0.173	CbGbCtD
Telmisartan—ABCC2—Sulfasalazine—Crohn's disease	0.0446	0.0523	CbGbCtD
Telmisartan—ABCG2—Sulfasalazine—Crohn's disease	0.0403	0.0472	CbGbCtD
Telmisartan—CYP2C19—Prednisone—Crohn's disease	0.0144	0.0169	CbGbCtD
Telmisartan—ABCB1—Prednisone—Crohn's disease	0.0116	0.0136	CbGbCtD
Telmisartan—ABCC2—bile—Crohn's disease	0.00482	0.316	CbGeAlD
Telmisartan—AGTR1—Arf6 trafficking events—VAMP3—Crohn's disease	0.00341	0.0971	CbGpPWpGaD
Telmisartan—PPARG—Methyldopa—Mesalazine—Crohn's disease	0.00244	1	CbGdCrCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00179	0.051	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.00105	0.0299	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.000968	0.0276	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000962	0.0274	CbGpPWpGaD
Telmisartan—AGTR1—epithelium—Crohn's disease	0.000958	0.0627	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—Crohn's disease	0.000923	0.0604	CbGeAlD
Telmisartan—PPARG—epithelium—Crohn's disease	0.000788	0.0516	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—Crohn's disease	0.000759	0.0497	CbGeAlD
Telmisartan—PPARG—skin of body—Crohn's disease	0.000749	0.0491	CbGeAlD
Telmisartan—AGTR1—Allograft Rejection—LRRK2—Crohn's disease	0.000743	0.0211	CbGpPWpGaD
Telmisartan—AGTR1—lymphoid tissue—Crohn's disease	0.000738	0.0483	CbGeAlD
Telmisartan—SLCO1B3—Transport of organic anions—ALB—Crohn's disease	0.000722	0.0206	CbGpPWpGaD
Telmisartan—AGTR1—Peptide GPCRs—CCR9—Crohn's disease	0.000716	0.0204	CbGpPWpGaD
Telmisartan—PPARG—mammalian vulva—Crohn's disease	0.000683	0.0447	CbGeAlD
Telmisartan—Influenza like illness—Mesalazine—Crohn's disease	0.000658	0.00704	CcSEcCtD
Telmisartan—Cystitis—Mesalazine—Crohn's disease	0.000654	0.007	CcSEcCtD
Telmisartan—Vaginal infection—Mesalazine—Crohn's disease	0.00064	0.00684	CcSEcCtD
Telmisartan—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000622	0.00666	CcSEcCtD
Telmisartan—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000618	0.00661	CcSEcCtD
Telmisartan—Bladder pain—Mesalazine—Crohn's disease	0.000613	0.00655	CcSEcCtD
Telmisartan—PPARG—lymphoid tissue—Crohn's disease	0.000607	0.0397	CbGeAlD
Telmisartan—PPARG—digestive system—Crohn's disease	0.000599	0.0392	CbGeAlD
Telmisartan—Hypertonia—Mesalazine—Crohn's disease	0.000594	0.00635	CcSEcCtD
Telmisartan—Ear pain—Mesalazine—Crohn's disease	0.000576	0.00617	CcSEcCtD
Telmisartan—Immune system disorder—Mercaptopurine—Crohn's disease	0.000566	0.00606	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—GCKR—Crohn's disease	0.000559	0.0159	CbGpPWpGaD
Telmisartan—Gastroenteritis—Mesalazine—Crohn's disease	0.000555	0.00594	CcSEcCtD
Telmisartan—Eczema—Mesalazine—Crohn's disease	0.000547	0.00585	CcSEcCtD
Telmisartan—Malnutrition—Mercaptopurine—Crohn's disease	0.000546	0.00584	CcSEcCtD
Telmisartan—SLCO1B3—Recycling of bile acids and salts—ALB—Crohn's disease	0.000535	0.0152	CbGpPWpGaD
Telmisartan—Renal failure acute—Mesalazine—Crohn's disease	0.000533	0.0057	CcSEcCtD
Telmisartan—ABCC2—digestive system—Crohn's disease	0.000527	0.0345	CbGeAlD
Telmisartan—AGTR1—Arf6 trafficking events—ITGA4—Crohn's disease	0.000524	0.0149	CbGpPWpGaD
Telmisartan—Increased appetite—Mesalazine—Crohn's disease	0.000523	0.0056	CcSEcCtD
Telmisartan—Atrial fibrillation—Mesalazine—Crohn's disease	0.000519	0.00555	CcSEcCtD
Telmisartan—Renal impairment—Mesalazine—Crohn's disease	0.000517	0.00553	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.000512	0.0146	CbGpPWpGaD
Telmisartan—Arthritis—Mesalazine—Crohn's disease	0.000506	0.00541	CcSEcCtD
Telmisartan—Anaemia—Mercaptopurine—Crohn's disease	0.000504	0.0054	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—MLN—Crohn's disease	0.000492	0.014	CbGpPWpGaD
Telmisartan—Osteoarthritis—Mesalazine—Crohn's disease	0.000492	0.00526	CcSEcCtD
Telmisartan—PPARG—Noncanonical Wnt signaling pathway—TAB1—Crohn's disease	0.00049	0.0139	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.000486	0.0138	CbGpPWpGaD
Telmisartan—Migraine—Mesalazine—Crohn's disease	0.000484	0.00518	CcSEcCtD
Telmisartan—Face oedema—Mesalazine—Crohn's disease	0.000475	0.00508	CcSEcCtD
Telmisartan—AGTR1—Peptide GPCRs—CCR6—Crohn's disease	0.000474	0.0135	CbGpPWpGaD
Telmisartan—Arthralgia—Mercaptopurine—Crohn's disease	0.000465	0.00497	CcSEcCtD
Telmisartan—Fungal infection—Prednisone—Crohn's disease	0.000464	0.00497	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000461	0.00494	CcSEcCtD
Telmisartan—Blood creatinine increased—Mesalazine—Crohn's disease	0.000461	0.00493	CcSEcCtD
Telmisartan—Abscess—Prednisone—Crohn's disease	0.000453	0.00485	CcSEcCtD
Telmisartan—CYP2C19—digestive system—Crohn's disease	0.000453	0.0296	CbGeAlD
Telmisartan—Dry skin—Mesalazine—Crohn's disease	0.000451	0.00482	CcSEcCtD
Telmisartan—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000449	0.00481	CcSEcCtD
Telmisartan—Abdominal discomfort—Azathioprine—Crohn's disease	0.000447	0.00479	CcSEcCtD
Telmisartan—Oedema—Mercaptopurine—Crohn's disease	0.000445	0.00476	CcSEcCtD
Telmisartan—Breast disorder—Mesalazine—Crohn's disease	0.000444	0.00475	CcSEcCtD
Telmisartan—Cramp muscle—Mesalazine—Crohn's disease	0.000443	0.00474	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00044	0.0125	CbGpPWpGaD
Telmisartan—ABCG2—mammalian vulva—Crohn's disease	0.000438	0.0287	CbGeAlD
Telmisartan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000436	0.00467	CcSEcCtD
Telmisartan—Gastritis—Mesalazine—Crohn's disease	0.000435	0.00466	CcSEcCtD
Telmisartan—Skin disorder—Mercaptopurine—Crohn's disease	0.000433	0.00463	CcSEcCtD
Telmisartan—Abdominal distension—Mesalazine—Crohn's disease	0.000428	0.00458	CcSEcCtD
Telmisartan—Asthma—Mesalazine—Crohn's disease	0.000425	0.00455	CcSEcCtD
Telmisartan—Anorexia—Mercaptopurine—Crohn's disease	0.000425	0.00454	CcSEcCtD
Telmisartan—Eosinophilia—Mesalazine—Crohn's disease	0.000421	0.0045	CcSEcCtD
Telmisartan—Pneumonia—Azathioprine—Crohn's disease	0.000419	0.00448	CcSEcCtD
Telmisartan—Bronchospasm—Mesalazine—Crohn's disease	0.000418	0.00447	CcSEcCtD
Telmisartan—AGTR1—lymph node—Crohn's disease	0.000416	0.0273	CbGeAlD
Telmisartan—Infestation—Azathioprine—Crohn's disease	0.000416	0.00445	CcSEcCtD
Telmisartan—Infestation NOS—Azathioprine—Crohn's disease	0.000416	0.00445	CcSEcCtD
Telmisartan—Angina pectoris—Mesalazine—Crohn's disease	0.000414	0.00443	CcSEcCtD
Telmisartan—Bronchitis—Mesalazine—Crohn's disease	0.000409	0.00437	CcSEcCtD
Telmisartan—Abdominal discomfort—Mesalazine—Crohn's disease	0.000408	0.00436	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000406	0.00434	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.000401	0.0114	CbGpPWpGaD
Telmisartan—Dysuria—Mesalazine—Crohn's disease	0.000397	0.00425	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000395	0.00423	CcSEcCtD
Telmisartan—Arthropathy—Prednisone—Crohn's disease	0.000394	0.00422	CcSEcCtD
Telmisartan—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000394	0.00421	CcSEcCtD
Telmisartan—Pollakiuria—Mesalazine—Crohn's disease	0.000393	0.0042	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL17A—Crohn's disease	0.00039	0.0111	CbGpPWpGaD
Telmisartan—Decreased appetite—Mercaptopurine—Crohn's disease	0.000387	0.00414	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000385	0.00411	CcSEcCtD
Telmisartan—Pneumonia—Mesalazine—Crohn's disease	0.000381	0.00408	CcSEcCtD
Telmisartan—Infestation—Mesalazine—Crohn's disease	0.000379	0.00405	CcSEcCtD
Telmisartan—Infestation NOS—Mesalazine—Crohn's disease	0.000379	0.00405	CcSEcCtD
Telmisartan—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000379	0.00405	CcSEcCtD
Telmisartan—Depression—Mesalazine—Crohn's disease	0.000378	0.00404	CcSEcCtD
Telmisartan—Renal failure—Mesalazine—Crohn's disease	0.000373	0.00399	CcSEcCtD
Telmisartan—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000372	0.00397	CcSEcCtD
Telmisartan—Conjunctivitis—Mesalazine—Crohn's disease	0.000368	0.00394	CcSEcCtD
Telmisartan—Urinary tract infection—Mesalazine—Crohn's disease	0.000368	0.00394	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL12B—Crohn's disease	0.000363	0.0103	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	0.000362	0.0103	CbGpPWpGaD
Telmisartan—Haematuria—Mesalazine—Crohn's disease	0.000361	0.00387	CcSEcCtD
Telmisartan—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000358	0.00383	CcSEcCtD
Telmisartan—Epistaxis—Mesalazine—Crohn's disease	0.000357	0.00382	CcSEcCtD
Telmisartan—Sinusitis—Mesalazine—Crohn's disease	0.000356	0.0038	CcSEcCtD
Telmisartan—Body temperature increased—Mercaptopurine—Crohn's disease	0.000352	0.00377	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000344	0.00978	CbGpPWpGaD
Telmisartan—PPARG—lymph node—Crohn's disease	0.000342	0.0224	CbGeAlD
Telmisartan—Rhinitis—Mesalazine—Crohn's disease	0.000341	0.00365	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—FADS1—Crohn's disease	0.000339	0.00966	CbGpPWpGaD
Telmisartan—Pharyngitis—Mesalazine—Crohn's disease	0.000338	0.00361	CcSEcCtD
Telmisartan—Immune system disorder—Azathioprine—Crohn's disease	0.000337	0.00361	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.000337	0.00958	CbGpPWpGaD
Telmisartan—Mediastinal disorder—Azathioprine—Crohn's disease	0.000337	0.0036	CcSEcCtD
Telmisartan—Urinary tract disorder—Mesalazine—Crohn's disease	0.000336	0.00359	CcSEcCtD
Telmisartan—Oedema peripheral—Mesalazine—Crohn's disease	0.000335	0.00359	CcSEcCtD
Telmisartan—Chills—Azathioprine—Crohn's disease	0.000335	0.00359	CcSEcCtD
Telmisartan—Connective tissue disorder—Mesalazine—Crohn's disease	0.000334	0.00358	CcSEcCtD
Telmisartan—Arrhythmia—Azathioprine—Crohn's disease	0.000334	0.00357	CcSEcCtD
Telmisartan—Urethral disorder—Mesalazine—Crohn's disease	0.000334	0.00357	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.000332	0.00945	CbGpPWpGaD
Telmisartan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000328	0.00351	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000326	0.00927	CbGpPWpGaD
Telmisartan—Eye disorder—Mesalazine—Crohn's disease	0.000318	0.0034	CcSEcCtD
Telmisartan—Tinnitus—Mesalazine—Crohn's disease	0.000317	0.00339	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—GPR65—Crohn's disease	0.000317	0.00902	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—CREM—Crohn's disease	0.000316	0.009	CbGpPWpGaD
Telmisartan—Cardiac disorder—Mesalazine—Crohn's disease	0.000316	0.00338	CcSEcCtD
Telmisartan—Sepsis—Prednisone—Crohn's disease	0.000311	0.00333	CcSEcCtD
Telmisartan—Angiopathy—Mesalazine—Crohn's disease	0.000309	0.0033	CcSEcCtD
Telmisartan—Immune system disorder—Mesalazine—Crohn's disease	0.000307	0.00329	CcSEcCtD
Telmisartan—Mediastinal disorder—Mesalazine—Crohn's disease	0.000307	0.00328	CcSEcCtD
Telmisartan—Chills—Mesalazine—Crohn's disease	0.000305	0.00327	CcSEcCtD
Telmisartan—Diarrhoea—Mercaptopurine—Crohn's disease	0.000305	0.00326	CcSEcCtD
Telmisartan—Ill-defined disorder—Azathioprine—Crohn's disease	0.000302	0.00323	CcSEcCtD
Telmisartan—ABCC2—lymph node—Crohn's disease	0.000301	0.0197	CbGeAlD
Telmisartan—Anaemia—Azathioprine—Crohn's disease	0.000301	0.00322	CcSEcCtD
Telmisartan—Diabetes mellitus—Prednisone—Crohn's disease	0.000299	0.0032	CcSEcCtD
Telmisartan—Mental disorder—Mesalazine—Crohn's disease	0.000298	0.00319	CcSEcCtD
Telmisartan—Erythema—Mesalazine—Crohn's disease	0.000296	0.00317	CcSEcCtD
Telmisartan—Malaise—Azathioprine—Crohn's disease	0.000293	0.00314	CcSEcCtD
Telmisartan—Flatulence—Mesalazine—Crohn's disease	0.000292	0.00312	CcSEcCtD
Telmisartan—Vascular purpura—Prednisone—Crohn's disease	0.000291	0.00311	CcSEcCtD
Telmisartan—Tension—Mesalazine—Crohn's disease	0.000291	0.00311	CcSEcCtD
Telmisartan—Dysgeusia—Mesalazine—Crohn's disease	0.00029	0.0031	CcSEcCtD
Telmisartan—Nervousness—Mesalazine—Crohn's disease	0.000288	0.00308	CcSEcCtD
Telmisartan—Cardiac failure congestive—Prednisone—Crohn's disease	0.000287	0.00307	CcSEcCtD
Telmisartan—Back pain—Mesalazine—Crohn's disease	0.000286	0.00307	CcSEcCtD
Telmisartan—Muscle spasms—Mesalazine—Crohn's disease	0.000285	0.00305	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.000284	0.00807	CbGpPWpGaD
Telmisartan—Vomiting—Mercaptopurine—Crohn's disease	0.000283	0.00303	CcSEcCtD
Telmisartan—Rash—Mercaptopurine—Crohn's disease	0.000281	0.003	CcSEcCtD
Telmisartan—Dermatitis—Mercaptopurine—Crohn's disease	0.000281	0.003	CcSEcCtD
Telmisartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00028	0.00796	CbGpPWpGaD
Telmisartan—Increased appetite—Prednisone—Crohn's disease	0.000277	0.00296	CcSEcCtD
Telmisartan—Myalgia—Azathioprine—Crohn's disease	0.000277	0.00296	CcSEcCtD
Telmisartan—Arthralgia—Azathioprine—Crohn's disease	0.000277	0.00296	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000275	0.00294	CcSEcCtD
Telmisartan—Ill-defined disorder—Mesalazine—Crohn's disease	0.000275	0.00294	CcSEcCtD
Telmisartan—Anaemia—Mesalazine—Crohn's disease	0.000274	0.00293	CcSEcCtD
Telmisartan—Discomfort—Azathioprine—Crohn's disease	0.000274	0.00293	CcSEcCtD
Telmisartan—Angioedema—Mesalazine—Crohn's disease	0.000271	0.0029	CcSEcCtD
Telmisartan—Purpura—Prednisone—Crohn's disease	0.00027	0.00289	CcSEcCtD
Telmisartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000268	0.00762	CbGpPWpGaD
Telmisartan—Malaise—Mesalazine—Crohn's disease	0.000267	0.00286	CcSEcCtD
Telmisartan—Vertigo—Mesalazine—Crohn's disease	0.000266	0.00285	CcSEcCtD
Telmisartan—Syncope—Mesalazine—Crohn's disease	0.000266	0.00284	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL10—Crohn's disease	0.000265	0.00755	CbGpPWpGaD
Telmisartan—Nausea—Mercaptopurine—Crohn's disease	0.000265	0.00283	CcSEcCtD
Telmisartan—Infection—Azathioprine—Crohn's disease	0.000264	0.00282	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000264	0.0075	CbGpPWpGaD
Telmisartan—Palpitations—Mesalazine—Crohn's disease	0.000262	0.0028	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—ACKR2—Crohn's disease	0.000262	0.00745	CbGpPWpGaD
Telmisartan—Loss of consciousness—Mesalazine—Crohn's disease	0.00026	0.00279	CcSEcCtD
Telmisartan—Osteoarthritis—Prednisone—Crohn's disease	0.00026	0.00278	CcSEcCtD
Telmisartan—Thrombocytopenia—Azathioprine—Crohn's disease	0.00026	0.00278	CcSEcCtD
Telmisartan—Cough—Mesalazine—Crohn's disease	0.000258	0.00277	CcSEcCtD
Telmisartan—Skin disorder—Azathioprine—Crohn's disease	0.000258	0.00276	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000256	0.0073	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000256	0.0073	CbGpPWpGaD
Telmisartan—Hypertension—Mesalazine—Crohn's disease	0.000256	0.00274	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	0.000254	0.00722	CbGpPWpGaD
Telmisartan—Arthralgia—Mesalazine—Crohn's disease	0.000252	0.0027	CcSEcCtD
Telmisartan—Chest pain—Mesalazine—Crohn's disease	0.000252	0.0027	CcSEcCtD
Telmisartan—Myalgia—Mesalazine—Crohn's disease	0.000252	0.0027	CcSEcCtD
Telmisartan—Anxiety—Mesalazine—Crohn's disease	0.000251	0.00269	CcSEcCtD
Telmisartan—Face oedema—Prednisone—Crohn's disease	0.000251	0.00269	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00025	0.00268	CcSEcCtD
Telmisartan—Discomfort—Mesalazine—Crohn's disease	0.000249	0.00267	CcSEcCtD
Telmisartan—ABCB1—epithelium—Crohn's disease	0.000249	0.0163	CbGeAlD
Telmisartan—AGTR1—GPCR ligand binding—MLN—Crohn's disease	0.000248	0.00706	CbGpPWpGaD
Telmisartan—Hypotension—Azathioprine—Crohn's disease	0.000248	0.00265	CcSEcCtD
Telmisartan—Dry mouth—Mesalazine—Crohn's disease	0.000247	0.00264	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000245	0.00698	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000242	0.00259	CcSEcCtD
Telmisartan—Oedema—Mesalazine—Crohn's disease	0.000242	0.00259	CcSEcCtD
Telmisartan—Anaphylactic shock—Mesalazine—Crohn's disease	0.000242	0.00259	CcSEcCtD
Telmisartan—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000241	0.00686	CbGpPWpGaD
Telmisartan—Infection—Mesalazine—Crohn's disease	0.00024	0.00257	CcSEcCtD
Telmisartan—Dry skin—Prednisone—Crohn's disease	0.000239	0.00255	CcSEcCtD
Telmisartan—Shock—Mesalazine—Crohn's disease	0.000238	0.00254	CcSEcCtD
Telmisartan—Nervous system disorder—Mesalazine—Crohn's disease	0.000237	0.00254	CcSEcCtD
Telmisartan—Hypokalaemia—Prednisone—Crohn's disease	0.000237	0.00253	CcSEcCtD
Telmisartan—Thrombocytopenia—Mesalazine—Crohn's disease	0.000237	0.00253	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL2RA—Crohn's disease	0.000236	0.00673	CbGpPWpGaD
Telmisartan—Tachycardia—Mesalazine—Crohn's disease	0.000236	0.00252	CcSEcCtD
Telmisartan—Skin disorder—Mesalazine—Crohn's disease	0.000235	0.00251	CcSEcCtD
Telmisartan—Hyperhidrosis—Mesalazine—Crohn's disease	0.000234	0.0025	CcSEcCtD
Telmisartan—Anorexia—Mesalazine—Crohn's disease	0.00023	0.00247	CcSEcCtD
Telmisartan—Muscular weakness—Prednisone—Crohn's disease	0.00023	0.00246	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000229	0.00245	CcSEcCtD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000229	0.00651	CbGpPWpGaD
Telmisartan—Abdominal distension—Prednisone—Crohn's disease	0.000226	0.00242	CcSEcCtD
Telmisartan—Hypotension—Mesalazine—Crohn's disease	0.000226	0.00242	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000226	0.00643	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000223	0.00635	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00022	0.00236	CcSEcCtD
Telmisartan—ABCG2—lymph node—Crohn's disease	0.000219	0.0144	CbGeAlD
Telmisartan—Sweating increased—Prednisone—Crohn's disease	0.000219	0.00234	CcSEcCtD
Telmisartan—Feeling abnormal—Azathioprine—Crohn's disease	0.000219	0.00234	CcSEcCtD
Telmisartan—Insomnia—Mesalazine—Crohn's disease	0.000219	0.00234	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000218	0.00621	CbGpPWpGaD
Telmisartan—Paraesthesia—Mesalazine—Crohn's disease	0.000217	0.00232	CcSEcCtD
Telmisartan—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000217	0.00232	CcSEcCtD
Telmisartan—ABCB1—mammalian vulva—Crohn's disease	0.000216	0.0141	CbGeAlD
Telmisartan—Dyspnoea—Mesalazine—Crohn's disease	0.000216	0.00231	CcSEcCtD
Telmisartan—Somnolence—Mesalazine—Crohn's disease	0.000215	0.0023	CcSEcCtD
Telmisartan—Dyspepsia—Mesalazine—Crohn's disease	0.000213	0.00228	CcSEcCtD
Telmisartan—Decreased appetite—Mesalazine—Crohn's disease	0.00021	0.00225	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00021	0.00598	CbGpPWpGaD
Telmisartan—Body temperature increased—Azathioprine—Crohn's disease	0.00021	0.00224	CcSEcCtD
Telmisartan—Abdominal pain—Azathioprine—Crohn's disease	0.00021	0.00224	CcSEcCtD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	0.000209	0.00595	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000209	0.00223	CcSEcCtD
Telmisartan—Fatigue—Mesalazine—Crohn's disease	0.000208	0.00223	CcSEcCtD
Telmisartan—Erectile dysfunction—Prednisone—Crohn's disease	0.000207	0.00222	CcSEcCtD
Telmisartan—Constipation—Mesalazine—Crohn's disease	0.000207	0.00221	CcSEcCtD
Telmisartan—Pain—Mesalazine—Crohn's disease	0.000207	0.00221	CcSEcCtD
Telmisartan—Depression—Prednisone—Crohn's disease	0.0002	0.00214	CcSEcCtD
Telmisartan—Feeling abnormal—Mesalazine—Crohn's disease	0.000199	0.00213	CcSEcCtD
Telmisartan—Acute coronary syndrome—Prednisone—Crohn's disease	0.000198	0.00211	CcSEcCtD
Telmisartan—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000198	0.00211	CcSEcCtD
Telmisartan—Myocardial infarction—Prednisone—Crohn's disease	0.000197	0.0021	CcSEcCtD
Telmisartan—Neuropathy peripheral—Prednisone—Crohn's disease	0.000197	0.0021	CcSEcCtD
Telmisartan—Hypersensitivity—Azathioprine—Crohn's disease	0.000196	0.00209	CcSEcCtD
Telmisartan—Urticaria—Mesalazine—Crohn's disease	0.000192	0.00205	CcSEcCtD
Telmisartan—ABCB1—lymphoid tissue—Crohn's disease	0.000192	0.0126	CbGeAlD
Telmisartan—Abdominal pain—Mesalazine—Crohn's disease	0.000191	0.00204	CcSEcCtD
Telmisartan—Body temperature increased—Mesalazine—Crohn's disease	0.000191	0.00204	CcSEcCtD
Telmisartan—ABCB1—digestive system—Crohn's disease	0.000189	0.0124	CbGeAlD
Telmisartan—Bradycardia—Prednisone—Crohn's disease	0.000183	0.00196	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000183	0.0052	CbGpPWpGaD
Telmisartan—Diarrhoea—Azathioprine—Crohn's disease	0.000182	0.00194	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000181	0.00514	CbGpPWpGaD
Telmisartan—Hypersensitivity—Mesalazine—Crohn's disease	0.000178	0.00191	CcSEcCtD
Telmisartan—Connective tissue disorder—Prednisone—Crohn's disease	0.000177	0.00189	CcSEcCtD
Telmisartan—Dizziness—Azathioprine—Crohn's disease	0.000175	0.00188	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000175	0.00497	CbGpPWpGaD
Telmisartan—Asthenia—Mesalazine—Crohn's disease	0.000173	0.00186	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CCR9—Crohn's disease	0.000172	0.0049	CbGpPWpGaD
Telmisartan—Pruritus—Mesalazine—Crohn's disease	0.000171	0.00183	CcSEcCtD
Telmisartan—Vomiting—Azathioprine—Crohn's disease	0.000169	0.00181	CcSEcCtD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	0.000169	0.0048	CbGpPWpGaD
Telmisartan—Eye disorder—Prednisone—Crohn's disease	0.000168	0.0018	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	0.000167	0.00477	CbGpPWpGaD
Telmisartan—Rash—Azathioprine—Crohn's disease	0.000167	0.00179	CcSEcCtD
Telmisartan—Dermatitis—Azathioprine—Crohn's disease	0.000167	0.00179	CcSEcCtD
Telmisartan—Flushing—Prednisone—Crohn's disease	0.000167	0.00179	CcSEcCtD
Telmisartan—Headache—Azathioprine—Crohn's disease	0.000166	0.00178	CcSEcCtD
Telmisartan—Diarrhoea—Mesalazine—Crohn's disease	0.000165	0.00177	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000164	0.00466	CbGpPWpGaD
Telmisartan—Angiopathy—Prednisone—Crohn's disease	0.000163	0.00175	CcSEcCtD
Telmisartan—Immune system disorder—Prednisone—Crohn's disease	0.000163	0.00174	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000161	0.00459	CbGpPWpGaD
Telmisartan—Arrhythmia—Prednisone—Crohn's disease	0.000161	0.00172	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Crohn's disease	0.000161	0.00457	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.00016	0.00456	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—GPR65—Crohn's disease	0.00016	0.00455	CbGpPWpGaD
Telmisartan—Dizziness—Mesalazine—Crohn's disease	0.00016	0.00171	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00016	0.00455	CbGpPWpGaD
Telmisartan—Mental disorder—Prednisone—Crohn's disease	0.000158	0.00169	CcSEcCtD
Telmisartan—Nausea—Azathioprine—Crohn's disease	0.000158	0.00169	CcSEcCtD
Telmisartan—Erythema—Prednisone—Crohn's disease	0.000157	0.00168	CcSEcCtD
Telmisartan—Malnutrition—Prednisone—Crohn's disease	0.000157	0.00168	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IFNG—Crohn's disease	0.000156	0.00444	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	0.000156	0.00443	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000154	0.00438	CbGpPWpGaD
Telmisartan—Vomiting—Mesalazine—Crohn's disease	0.000154	0.00164	CcSEcCtD
Telmisartan—Rash—Mesalazine—Crohn's disease	0.000152	0.00163	CcSEcCtD
Telmisartan—Dermatitis—Mesalazine—Crohn's disease	0.000152	0.00163	CcSEcCtD
Telmisartan—Headache—Mesalazine—Crohn's disease	0.000151	0.00162	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00015	0.00426	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—SOCS1—Crohn's disease	0.000148	0.00421	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000147	0.00417	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Crohn's disease	0.000146	0.00414	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Prednisone—Crohn's disease	0.000145	0.00156	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—CXCL8—Crohn's disease	0.000145	0.00413	CbGpPWpGaD
Telmisartan—Anaemia—Prednisone—Crohn's disease	0.000145	0.00155	CcSEcCtD
Telmisartan—Nausea—Mesalazine—Crohn's disease	0.000144	0.00154	CcSEcCtD
Telmisartan—Angioedema—Prednisone—Crohn's disease	0.000143	0.00153	CcSEcCtD
Telmisartan—Malaise—Prednisone—Crohn's disease	0.000141	0.00151	CcSEcCtD
Telmisartan—Vertigo—Prednisone—Crohn's disease	0.000141	0.00151	CcSEcCtD
Telmisartan—Syncope—Prednisone—Crohn's disease	0.000141	0.0015	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—MLN—Crohn's disease	0.00014	0.00399	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL1B—Crohn's disease	0.000139	0.00396	CbGpPWpGaD
Telmisartan—Loss of consciousness—Prednisone—Crohn's disease	0.000138	0.00147	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000138	0.00391	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000137	0.0039	CbGpPWpGaD
Telmisartan—Hypertension—Prednisone—Crohn's disease	0.000135	0.00145	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—ACKR2—Crohn's disease	0.000134	0.00382	CbGpPWpGaD
Telmisartan—Arthralgia—Prednisone—Crohn's disease	0.000133	0.00143	CcSEcCtD
Telmisartan—Myalgia—Prednisone—Crohn's disease	0.000133	0.00143	CcSEcCtD
Telmisartan—Anxiety—Prednisone—Crohn's disease	0.000133	0.00142	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000132	0.00142	CcSEcCtD
Telmisartan—Discomfort—Prednisone—Crohn's disease	0.000132	0.00141	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000132	0.00375	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00013	0.00371	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00013	0.00371	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Prednisone—Crohn's disease	0.000128	0.00137	CcSEcCtD
Telmisartan—Oedema—Prednisone—Crohn's disease	0.000128	0.00137	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—SMAD3—Crohn's disease	0.000128	0.00363	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MLN—Crohn's disease	0.000127	0.00362	CbGpPWpGaD
Telmisartan—Infection—Prednisone—Crohn's disease	0.000127	0.00136	CcSEcCtD
Telmisartan—Shock—Prednisone—Crohn's disease	0.000126	0.00135	CcSEcCtD
Telmisartan—Nervous system disorder—Prednisone—Crohn's disease	0.000125	0.00134	CcSEcCtD
Telmisartan—Tachycardia—Prednisone—Crohn's disease	0.000125	0.00134	CcSEcCtD
Telmisartan—Skin disorder—Prednisone—Crohn's disease	0.000124	0.00133	CcSEcCtD
Telmisartan—Hyperhidrosis—Prednisone—Crohn's disease	0.000124	0.00132	CcSEcCtD
Telmisartan—Anorexia—Prednisone—Crohn's disease	0.000122	0.0013	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000121	0.00344	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000117	0.00333	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000117	0.00125	CcSEcCtD
Telmisartan—Insomnia—Prednisone—Crohn's disease	0.000116	0.00124	CcSEcCtD
Telmisartan—Paraesthesia—Prednisone—Crohn's disease	0.000115	0.00123	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000115	0.00326	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCR6—Crohn's disease	0.000114	0.00324	CbGpPWpGaD
Telmisartan—Dyspepsia—Prednisone—Crohn's disease	0.000113	0.0012	CcSEcCtD
Telmisartan—Decreased appetite—Prednisone—Crohn's disease	0.000111	0.00119	CcSEcCtD
Telmisartan—Fatigue—Prednisone—Crohn's disease	0.00011	0.00118	CcSEcCtD
Telmisartan—Constipation—Prednisone—Crohn's disease	0.000109	0.00117	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	0.000108	0.00308	CbGpPWpGaD
Telmisartan—ABCB1—lymph node—Crohn's disease	0.000108	0.00708	CbGeAlD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000107	0.00304	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000106	0.00303	CbGpPWpGaD
Telmisartan—Feeling abnormal—Prednisone—Crohn's disease	0.000105	0.00113	CcSEcCtD
Telmisartan—Gastrointestinal pain—Prednisone—Crohn's disease	0.000105	0.00112	CcSEcCtD
Telmisartan—PPARG—Gene Expression—PTRF—Crohn's disease	0.000104	0.00296	CbGpPWpGaD
Telmisartan—Urticaria—Prednisone—Crohn's disease	0.000102	0.00109	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—Crohn's disease	0.000101	0.00108	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—Crohn's disease	0.000101	0.00108	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—TNF—Crohn's disease	0.000101	0.00287	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—PTGER4—Crohn's disease	0.0001	0.00285	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.0001	0.00285	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR9—Crohn's disease	9.72e-05	0.00277	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—STAT3—Crohn's disease	9.56e-05	0.00272	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisone—Crohn's disease	9.42e-05	0.00101	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.32e-05	0.00265	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.32e-05	0.00265	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.18e-05	0.00261	CbGpPWpGaD
Telmisartan—Asthenia—Prednisone—Crohn's disease	9.18e-05	0.000982	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.11e-05	0.00259	CbGpPWpGaD
Telmisartan—Pruritus—Prednisone—Crohn's disease	9.05e-05	0.000968	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—GPR65—Crohn's disease	9.03e-05	0.00257	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	8.85e-05	0.00252	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR9—Crohn's disease	8.82e-05	0.00251	CbGpPWpGaD
Telmisartan—Diarrhoea—Prednisone—Crohn's disease	8.75e-05	0.000936	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	8.65e-05	0.00246	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.53e-05	0.00243	CbGpPWpGaD
Telmisartan—Dizziness—Prednisone—Crohn's disease	8.46e-05	0.000905	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—Crohn's disease	8.28e-05	0.00236	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GPR65—Crohn's disease	8.2e-05	0.00234	CbGpPWpGaD
Telmisartan—Vomiting—Prednisone—Crohn's disease	8.13e-05	0.00087	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.12e-05	0.00231	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.11e-05	0.00231	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.11e-05	0.00231	CbGpPWpGaD
Telmisartan—Rash—Prednisone—Crohn's disease	8.06e-05	0.000863	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—Crohn's disease	8.06e-05	0.000862	CcSEcCtD
Telmisartan—Headache—Prednisone—Crohn's disease	8.01e-05	0.000857	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—ACKR2—Crohn's disease	7.93e-05	0.00226	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—Crohn's disease	7.78e-05	0.00222	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	7.67e-05	0.00218	CbGpPWpGaD
Telmisartan—Nausea—Prednisone—Crohn's disease	7.6e-05	0.000813	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—MLN—Crohn's disease	7.52e-05	0.00214	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	7.48e-05	0.00213	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	7.19e-05	0.00205	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PLA2G4F—Crohn's disease	7.18e-05	0.00204	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	7.13e-05	0.00203	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	6.94e-05	0.00197	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TAGAP—Crohn's disease	6.88e-05	0.00196	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.57e-05	0.00187	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	6.51e-05	0.00185	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.48e-05	0.00185	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR6—Crohn's disease	6.44e-05	0.00183	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ZFP36L1—Crohn's disease	6.23e-05	0.00177	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PLA2G4F—Crohn's disease	6.12e-05	0.00174	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTMR3—Crohn's disease	6.1e-05	0.00174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RSPO3—Crohn's disease	6.01e-05	0.00171	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR6—Crohn's disease	5.85e-05	0.00166	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—STAT3—Crohn's disease	5.83e-05	0.00166	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.81e-05	0.00165	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.75e-05	0.00164	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.71e-05	0.00163	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SEL1L—Crohn's disease	5.7e-05	0.00162	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PTGER4—Crohn's disease	5.67e-05	0.00161	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.55e-05	0.00158	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—DNMT3A—Crohn's disease	5.29e-05	0.00151	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR9—Crohn's disease	5.21e-05	0.00148	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTMR3—Crohn's disease	5.21e-05	0.00148	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTGER4—Crohn's disease	5.15e-05	0.00147	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.05e-05	0.00144	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—Crohn's disease	5.05e-05	0.00144	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.89e-05	0.00139	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GPR65—Crohn's disease	4.85e-05	0.00138	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL3—Crohn's disease	4.83e-05	0.00137	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.82e-05	0.00137	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—FADS1—Crohn's disease	4.75e-05	0.00135	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.72e-05	0.00134	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	4.67e-05	0.00133	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—SMAD3—Crohn's disease	4.66e-05	0.00133	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IFNG—Crohn's disease	4.58e-05	0.0013	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLA2G4F—Crohn's disease	4.47e-05	0.00127	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GPX4—Crohn's disease	4.45e-05	0.00127	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—SMAD3—Crohn's disease	4.39e-05	0.00125	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL3—Crohn's disease	4.38e-05	0.00125	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.38e-05	0.00125	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.38e-05	0.00125	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GCKR—Crohn's disease	4.3e-05	0.00122	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	4.26e-05	0.00121	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RASGRP1—Crohn's disease	4.24e-05	0.00121	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL1B—Crohn's disease	4.08e-05	0.00116	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—Crohn's disease	4.07e-05	0.00116	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—FADS1—Crohn's disease	4.06e-05	0.00115	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GPX4—Crohn's disease	3.8e-05	0.00108	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTMR3—Crohn's disease	3.8e-05	0.00108	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.68e-05	0.00105	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL8—Crohn's disease	3.67e-05	0.00104	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GCKR—Crohn's disease	3.67e-05	0.00104	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.66e-05	0.00104	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HSPA1B—Crohn's disease	3.58e-05	0.00102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR6—Crohn's disease	3.45e-05	0.000983	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.45e-05	0.000981	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2RA—Crohn's disease	3.38e-05	0.000963	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—UBE2D1—Crohn's disease	3.14e-05	0.000893	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RBX1—Crohn's disease	3.12e-05	0.000889	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.09e-05	0.000879	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.07e-05	0.000875	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2RA—Crohn's disease	3.07e-05	0.000874	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTGER4—Crohn's disease	3.04e-05	0.000865	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—Crohn's disease	2.96e-05	0.000843	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—FADS1—Crohn's disease	2.96e-05	0.000842	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—Crohn's disease	2.92e-05	0.000832	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—Crohn's disease	2.87e-05	0.000818	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TYK2—Crohn's disease	2.86e-05	0.000814	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX4—Crohn's disease	2.77e-05	0.000789	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—UBE2D1—Crohn's disease	2.74e-05	0.00078	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.73e-05	0.000777	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—JAK2—Crohn's disease	2.73e-05	0.000777	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.69e-05	0.000765	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GCKR—Crohn's disease	2.68e-05	0.000762	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RIPK2—Crohn's disease	2.66e-05	0.000756	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.62e-05	0.000746	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL3—Crohn's disease	2.59e-05	0.000737	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RASGRP1—Crohn's disease	2.5e-05	0.000713	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	2.47e-05	0.000704	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.41e-05	0.000687	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.29e-05	0.000653	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—JAK2—Crohn's disease	2.27e-05	0.000647	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SOCS1—Crohn's disease	2.27e-05	0.000646	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SMAD3—Crohn's disease	2.24e-05	0.000639	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.17e-05	0.000616	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—TYK2—Crohn's disease	2.16e-05	0.000616	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTMR3—Crohn's disease	2.1e-05	0.000599	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.09e-05	0.000595	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—Crohn's disease	2.07e-05	0.000591	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—JAK2—Crohn's disease	2.06e-05	0.000588	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTMR3—Crohn's disease	2.05e-05	0.000584	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—Crohn's disease	2e-05	0.00057	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMAD3—Crohn's disease	1.96e-05	0.000558	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—Crohn's disease	1.88e-05	0.000536	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.82e-05	0.000517	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2RA—Crohn's disease	1.81e-05	0.000516	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—Crohn's disease	1.73e-05	0.000494	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FADS1—Crohn's disease	1.64e-05	0.000466	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FADS1—Crohn's disease	1.6e-05	0.000455	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX4—Crohn's disease	1.53e-05	0.000437	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX4—Crohn's disease	1.5e-05	0.000426	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCKR—Crohn's disease	1.48e-05	0.000422	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.46e-05	0.000416	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCKR—Crohn's disease	1.45e-05	0.000412	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—Crohn's disease	1.4e-05	0.000398	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—Crohn's disease	1.37e-05	0.00039	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TYK2—Crohn's disease	1.28e-05	0.000364	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAK2—Crohn's disease	1.22e-05	0.000347	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—Crohn's disease	1.2e-05	0.000341	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—Crohn's disease	1.17e-05	0.000332	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—Crohn's disease	1.11e-05	0.000317	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.06e-05	0.000301	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—Crohn's disease	1.06e-05	0.000301	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—Crohn's disease	1.02e-05	0.000291	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.83e-06	0.00028	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.26e-06	0.000264	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—Crohn's disease	8.95e-06	0.000255	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—Crohn's disease	8.51e-06	0.000242	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—Crohn's disease	7.45e-06	0.000212	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—Crohn's disease	6.25e-06	0.000178	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—Crohn's disease	4.72e-06	0.000134	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—Crohn's disease	4.6e-06	0.000131	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—Crohn's disease	4.13e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—Crohn's disease	4.03e-06	0.000115	CbGpPWpGaD
